10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
22.68
+0.63 (2.86%)
At close: Jan 21, 2026, 4:00 PM EST
22.85
+0.17 (0.75%)
Pre-market: Jan 22, 2026, 4:12 AM EST

10x Genomics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
2,8701,7386,6154,17116,64015,237
Upgrade
Market Cap Growth
51.99%-73.72%58.59%-74.93%9.21%107.79%
Upgrade
Enterprise Value
2,4751,4266,3573,81516,12014,530
Upgrade
Last Close Price
22.6814.3655.9636.44148.96141.60
Upgrade
PS Ratio
4.362.8510.698.0833.9250.99
Upgrade
PB Ratio
3.662.458.935.1820.3520.62
Upgrade
P/TBV Ratio
4.012.529.195.3621.1321.26
Upgrade
P/OCF Ratio
32.42260.86----
Upgrade
EV/Sales Ratio
3.862.3410.277.3932.8648.62
Upgrade
Debt / Equity Ratio
0.110.120.130.120.100.09
Upgrade
Asset Turnover
0.650.650.620.500.500.39
Upgrade
Inventory Turnover
2.562.502.701.701.652.59
Upgrade
Quick Ratio
3.934.093.964.086.106.05
Upgrade
Current Ratio
4.484.974.694.856.776.56
Upgrade
Return on Equity (ROE)
-10.12%-25.17%-32.98%-20.45%-7.48%-93.64%
Upgrade
Return on Assets (ROA)
-8.42%-12.77%-12.52%-9.99%-3.40%-6.95%
Upgrade
Return on Capital Employed (ROCE)
-15.00%-24.00%-23.80%-18.20%-5.80%-10.50%
Upgrade
Earnings Yield
-2.66%-10.51%-3.86%-3.98%-0.35%-3.56%
Upgrade
FCF Yield
2.84%-0.33%-0.96%-3.96%-0.74%-1.67%
Upgrade
Buyback Yield / Dilution
-3.07%-2.80%-2.90%-3.18%-9.09%-158.76%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q